Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

UBLITUXIMAB vs UMECLIDINIUM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

UBLITUXIMAB vs UMECLIDINIUM: Safety Overview

Metric UBLITUXIMAB UMECLIDINIUM
Total FAERS Reports 1,582 6,321
Deaths Reported 27 506
Death Rate 1.7% 8.0%
Hospitalizations 213 1,761
Average Patient Age 49.7 yrs 68.9 yrs
% Female Patients 73.4% 53.7%
FDA Approval Date N/A Apr 30, 2014
Manufacturer TG Therapeutics, Inc. GlaxoSmithKline LLC
Route INTRAVENOUS RESPIRATORY (INHALATION)
Marketing Status N/A Prescription